Home
Zobrazovací technika
Molekulární zobrazování

Biograph Vision

Molekulární zobrazování

Systémy pro molekulární zobrazování (MI) společnosti Siemens Healthineers odpovídají na klinické potřeby v onkologii, neurologii, kardiologii a radiologii a nabízejí přístroje PET/CT, SPECT a hybridní SPECT (SPECT/CT), které klinickým odborníkům pomáhají diagnostikovat, léčit a sledovat onemocnění s větší jistotou.

Molecular Imaging Clinical Corner

Molecular Imaging Clinical Corner

Immerse yourself in the clinical world of Molecular Imaging with on-demand resources to help grow your practice including clinical case studies, white papers, and webinars.

Nuclear Medicine News & Stories

Nuclear Medicine News & Stories

Your resource for the latest news, stories, and clinical cases in nuclear medicine and molecular imaging.

MIU_360thumb

Customer Portal Resource

Find information for gaining global support for preclinical research and development, cyclotrons, and chemistry solutions.

Nuclear Medicine News & Stories

Theranostics for neuroendocrine tumors: A patient’s experience

After receiving the diagnosis of neuroendocrine tumors, Glenda’s oncologist was unable to provide effective treatment options. Considering her disease burden and noting the progression of the tumors that were difficult to surgically remove, Glenda was referred for theranostics treatment.

Theranostics center of excellence: transforming oncology care

Nebraska Cancer Specialists in the midwestern region of the United States serves as a model of excellence in theranostics. While caring for the local community and attracting patients from across the country, the center also operates an extensive clinical trials program.

By Catherine Marcic Joyce

Highlights from the EANM 2024 Annual Congress

The European Association of Nuclear Medicine’s 37th Annual Meeting took place October 19–23, 2024, in Hamburg, Germany.

By Claudette Lew

PET/CT biomarkers enable clinicians to advance Alzheimer’s disease care

With the latest molecular imaging tools and biomarkers to enhance diagnostic accuracy and enable disease-modifying treatments, clinicians are paving the way for Alzheimer's disease care.

By Dr. K. G. Kallur, Noby Varghese, Abhinav Shanker, Ramya Rajaram

India’s increasing patient population benefits from operational excellence

An oncology team in Bengaluru, India, explains how they maximize their PET/CT scanner’s capabilities to better serve their increasing oncology patient population.

Go to News & Stories

Pomohly vám tyto informace?

* Biograph Vision is not commercially available in all countries. Due to regulatory reasons, its future availability cannot be guaranteed. Please contact your local Siemens organization for further details.

1

syngo.PET Amyloid Plaque is intended for use only with approved amyloid radiopharmaceuticals in the country of use. Users should review the drug labeling for approved uses.